Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

CardiAQ Valve Technologies v. Neovasc Inc., No. 17-1302 (Fed. Cir. Sept. 1, 2017)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1302
Also Docketed
No. 17-1513 (consolidated; same document)
Decided
September 1, 2017
Judge
Taranto, J.
Document
Nonprecedential Opinion
Length
26 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This is an action brought by CardiAQ Valve Techno l- ogies, Inc. against Neovasc Inc. and Neovasc Tiara Inc. (jointly, Neovasc). Founded by cardiac surgeon Dr. A r- shad Quadri , and soon joined by engineer Brent Ratz, CardiAQ set out to create a mitral-valve implant that could be delivered to the heart by catheter rather than open-heart surgery—a transcatheter mitral valve implant (TMVI). After developing several prototypes , CardiAQ engaged Neovasc to help with assembly of an aspect of the device.